NorthRock Partners LLC Acquires 1,944 Shares of Agilent Technologies, Inc. $A

NorthRock Partners LLC boosted its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 64.6% in the second quarter, Holdings Channel reports. The institutional investor owned 4,953 shares of the medical research company’s stock after acquiring an additional 1,944 shares during the quarter. NorthRock Partners LLC’s holdings in Agilent Technologies were worth $585,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the first quarter valued at $30,000. Ransom Advisory Ltd bought a new position in Agilent Technologies in the 1st quarter worth about $32,000. Central Pacific Bank Trust Division purchased a new position in Agilent Technologies during the 2nd quarter valued at about $33,000. Zions Bancorporation National Association UT purchased a new position in Agilent Technologies during the 1st quarter valued at about $38,000. Finally, Costello Asset Management INC bought a new stake in shares of Agilent Technologies during the first quarter valued at about $47,000.

Agilent Technologies Trading Up 0.8%

A stock opened at $139.14 on Thursday. The company has a market capitalization of $39.45 billion, a PE ratio of 32.66, a price-to-earnings-growth ratio of 4.51 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company’s 50 day moving average price is $126.49 and its two-hundred day moving average price is $117.46.

Agilent Technologies (NYSE:AGet Free Report) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.24%.

Analyst Ratings Changes

A number of equities analysts have recently commented on A shares. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. TD Cowen raised their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price target for the stock from $130.00 to $170.00 in a report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, Barclays boosted their target price on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $149.62.

Get Our Latest Analysis on A

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Further Reading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.